Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PROCEEDINGS OF THE 6^TH ROMANIAN CONGRESS OF NEUROENDOCRINOLOGY.

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC6525781 | biostudies-literature | 2018 Jul-Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

PROCEEDINGS OF THE 6TH ROMANIAN CONGRESS OF NEUROENDOCRINOLOGY.

Acta endocrinologica (Bucharest, Romania : 2005) 20180701 3

PMID: 31149293

Similar Datasets

34th European Congress of Pathology - Abstracts.

Project description: Not available

| S-EPMC9379246 | biostudies-literature

13th European Headache Federation Congress 2019 - Abstracts : May 30th to June 1st 2019. Athens, Greece.

Project description: Not available

| S-EPMC6904992 | biostudies-literature

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Project description:Focal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However, only a few RT-IT combinations have been tested successfully in patients with cancer, highlighting the urgent need for an improved understanding of the interaction between RT and IT in both preclinical and clinical scenarios. Every year since 2016, ImmunoRad gathers experts working at the interface between RT and IT to provide a forum for education and discussion, with the ultimate goal of fostering progress in the field at both preclinical and clinical levels. Here, we summarize the key concepts and findings presented at the Sixth Annual ImmunoRad conference.

| S-EPMC10286673 | biostudies-literature

18th International Congress of Pediatric Pulmonology Tokyo Chiba, June 27 - 30, 2019.

Project description: Not available

| S-EPMC7167664 | biostudies-literature

Proceedings of The 8th Romanian National HIV/AIDS Congress and The 3rd Central European HIV Forum : Sibiu, Romania. 5-7 May 2016.

Project description: Not available

| S-EPMC4928154 | biostudies-literature

Abstracts of the 20th International Congress of Neuropathology Berlin, Germany, September 13 - 16, 2023.

Project description: Not available

| S-EPMC10483180 | biostudies-literature

Poster Presentations - Abstracts of the 25th Annual Congress of the SBRA and the 15th REDLARA Taller General Rio de Janeiro/RJ - Brazil, 2021.

Project description: Not available

| S-EPMC8769188 | biostudies-literature

Proceedings of the 29th European Paediatric Rheumatology Congress.

Project description: Not available

| S-EPMC10580657 | biostudies-literature

Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.

Project description:The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted the striking clinical activity of T cells engineered to express either Chimeric Antigen (CAR) or T Cell (TCR) Receptors to target molecularly defined antigens expressed on tumor cells. The breakthrough of immunotherapy is represented by the approval of CAR-T cells specific for advanced or refractory CD19+ B cell malignancies by both the Food and Drug Administration (FDA) and the European Medicinal Agency (EMA). Moreover, advances in the manufacturing and gene editing of engineered immune cells contributed to the selection of drug products with desired phenotype, refined specificity and decreased toxicity. An important step toward the optimization of CAR-T cell therapy is the development of "off-the shelf" T cell products that allow to reduce the complexity and the costs of the manufacturing and to render these drugs available for a broad number of cancer patients. The Engineered Immune Cells in Cancer Immunotherapy (EICCI) workshop hosted in Doha, Qatar, renowned experts, from both academia and industry, to present and discuss the progress on both pre-clinical and clinical development of genetically modified immune cells, including advances in the "off-the-shelf" manufacturing. These experts have addressed also organizational needs and hurdles for the clinical grade production and application of these biological drugs.

| S-EPMC7874217 | biostudies-literature

Proceedings of Reanimation 2023, the French Intensive Care Society International Congress.

Project description: Not available

| S-EPMC10264219 | biostudies-literature